Political Intelligence

There is a whole industry built on knowing what Washington knows first.

Political intelligence is the practice of collecting non-public government information and selling it to hedge funds and asset managers to inform their trades. It operates in a regulatory gap with no disclosure requirements, no client transparency, and almost no public scrutiny. This is how it works.

~2,000

estimated people employed in political intelligence in the Washington D.C. area alone

63-86 bps

monthly outperformance of hedge funds with political intelligence access vs. non-connected funds, per academic research

$0

in mandatory disclosure required from political intelligence firms, despite lobbyists filing detailed quarterly reports

2012

the year Congress stripped a political intelligence registry provision from the STOCK Act in a same-day vote

What political intelligence actually means

Political intelligence has a formal legal definition, written into the STOCK Act of 2012: information that is "derived by a person from direct communications with an executive branch employee, a Member of Congress, or an employee of Congress; and provided in exchange for financial compensation to a client who intends, and who is known to intend, to use the information to inform investment decisions."

That is the legal version. The practical version is simpler. Political intelligence is the business of knowing what is about to happen in Washington before anyone else does, and selling that knowledge to the people who can profit from it.

This is distinct from lobbying in a way that matters enormously. Lobbyists work to change government decisions. They must register under the Lobbying Disclosure Act, file quarterly reports naming their clients, listing the issues they are working on, and disclosing how much they are paid. The entire system is designed to make influence over government visible.

Political intelligence firms do something different. They do not try to change government decisions. They try to predict them. And because they are not technically lobbying, they are exempt from every disclosure requirement that applies to lobbyists. No registration. No client lists. No activity reports. No compensation disclosure. A political intelligence firm can spend years collecting non-public information from congressional staff and selling it to a hedge fund, and none of that activity ever has to be reported to anyone.

How it works in practice

Political intelligence firms maintain networks of contacts across Capitol Hill, federal agencies, and the executive branch. Their analysts spend their days having conversations that would look entirely ordinary from the outside: calls with congressional staffers, meetings with agency staff, attendance at committee briefings that are nominally open to the public.

What they are doing is systematically sifting those conversations for signals about what government is about to decide. A Centers for Medicare and Medicaid Services analyst who mentions casually that a reimbursement rate is "trending lower than expected" may not realize they have just handed a political intelligence consultant something worth thousands of dollars to a hedge fund. A Senate Finance Committee staffer who indicates informally that a markup is unlikely to move forward this session may not think of that as trading-relevant information. It is.

The information gets assembled into research products, call transcripts, and investment notes distributed to paying clients. Hedge funds and asset managers pay monthly retainers for access to this flow. They are not buying predictions in a general sense. They are buying advance signals about specific government decisions that move specific stocks.

Channel checks

Systematic interviews with government staff, procurement officers, and agency insiders to gauge sentiment on pending decisions before they are officially announced. The term comes from supply-chain research; the practice is adapted for regulatory intelligence.

Regulatory calendar tracking

Monitoring FDA approval timelines, CMS reimbursement decision windows, Fed meeting schedules, and EPA rulemaking calendars. Knowing when a decision is likely to land, and positioning ahead of it, is valuable even before you know what the decision will be.

Vote outcome forecasting

Counting votes before they happen by gauging member positions through staff contacts and direct outreach. When a healthcare bill is heading to a floor vote, knowing whether it is likely to pass or fail has obvious implications for the sector's stocks.

Early access to committee output

Learning the substance of legislation being drafted in committee before it is formally released. Markup sessions, staff negotiations, and amendment discussions all happen in advance of any public record. Being in the right conversation at the right time is the core of the business.

The disclosure gap that makes this possible

If you want to lobby Congress, the law requires you to register under the Lobbying Disclosure Act. You file quarterly with the House Clerk and the Senate Secretary, listing every client, every issue you are working, every official you contacted, and how much you were paid. The public can look you up. Journalists can cross-reference your clients against committee votes. The system is imperfect but it exists.

Political intelligence has no equivalent. The Lobbying Disclosure Act defines lobbying as making direct communications with covered federal officials in an attempt to influence federal policy. Political intelligence firms argue, correctly, that they are not attempting to influence policy. They are gathering information about it. That definitional distinction creates a regulatory gap large enough to run a multi-billion-dollar information industry through.

A lobbying firm that represents a pharmaceutical company must disclose that representation, the issues they are working, and the officials they are contacting. A political intelligence firm that collects information from the same committee staff on the same issues, then sells that information to a hedge fund that holds the same pharmaceutical company's stock, discloses nothing. The second arrangement is, from a market fairness standpoint, arguably more concerning. But it is the one with no regulatory oversight at all.

Lobbying firm (regulated)

  • Must register with House Clerk and Senate Secretary
  • Must disclose client identities quarterly
  • Must report issue areas, specific bills, and officials contacted
  • Must disclose compensation received
  • Subject to revolving door waiting periods

Political intelligence firm (unregulated)

  • No registration requirement
  • No client disclosure
  • No activity or issue reporting
  • No compensation transparency
  • No revolving door restrictions

The provision Congress quietly removed

When the STOCK Act was making its way through Congress in 2012, Senator Chuck Grassley of Iowa introduced an amendment to address the political intelligence gap directly. His proposal would have required political intelligence firms to register and file disclosures similar to those required of lobbyists: who their clients are, what issues they are covering, and how much they are being paid. The amendment passed the Senate 60 to 39.

It never became law. House Majority Leader Eric Cantor stripped the provision before the final version of the bill came to a vote, arguing it needed more study. Both chambers voted to accept the stripped version on the same day. The political intelligence registry was gone, and the STOCK Act passed without it.

In place of Grassley's disclosure requirement, the law directed the Comptroller General to study the role of political intelligence in financial markets and report back to Congress. That report, GAO-13-389, was published in April 2013. Its conclusion was essentially that political intelligence is real, its market impact is real, and its scale is impossible to measure because there are no disclosure requirements. The GAO recommended Congress consider requiring disclosure. Congress did not act.

Grassley tried again in 2016 with the Political Intelligence Transparency Act, which would have amended the Lobbying Disclosure Act to cover political intelligence activities. It did not pass. As of early 2026, political intelligence firms still operate with no registration requirement, no client disclosure, and no mandatory transparency of any kind.

This is the context behind the more visible debate over congressional stock trading. The lawmakers trading stocks are generating headlines. The firms systematically monetizing congressional staff access for hedge fund clients are generating almost none. Both operate in the same information ecosystem.

The cases that prove the industry is real

These are the documented instances where the political intelligence pipeline from government officials to hedge fund trading desks was traced, prosecuted, and settled. Each ended in penalties. None resulted in the disclosure reforms that would make them detectable in advance.

B

Blaszczak, Worrall, and Deerfield Management: $3.9 million in CMS leak profits

SEC settlement, 2017

David Blaszczak was a former Centers for Medicare and Medicaid Services employee who left government and became a political intelligence consultant. His former colleague Christopher Worrall, still employed at CMS, passed him confidential information about upcoming decisions to cut Medicare reimbursement rates for medical providers. Blaszczak fed that information to analysts at Deerfield Management, a healthcare-focused hedge fund. Deerfield traded on the information and generated $3.9 million in illegal profits. Blaszczak's firms were paid at least $193,000 over 19 months for their services. Deerfield agreed to pay $4.6 million in disgorgement, interest, and civil penalties. The scheme worked because the link between a CMS insider and a hedge fund client ran through a political intelligence intermediary: a former government official who had monetized his relationships into a consulting practice.

M

Marwood Group and the Dendreon drug coverage decision

SEC Wells Notice, settled 2015

Marwood Group, a well-connected Washington political research firm, received a Wells Notice from the SEC relating to trades in Dendreon, a biotech company whose prostate cancer drug was under CMS coverage review. In June 2010, CMS decided to scale back coverage for Dendreon's Provenge drug. Dendreon's stock fell sharply in the weeks before that decision was announced publicly. The SEC's theory was that a CMS analyst had shared non-public information about the likely outcome, that Marwood knew or should have known this information was confidential, and that clients traded on it. Marwood paid $375,000 and admitted wrongdoing. The settlement acknowledged the firm had failed to establish and enforce policies to prevent trading on material non-public government information. It is one of the few cases where the line between legal political research and illegal insider trading was drawn in court-adjacent proceedings.

C

The broader CMS investigation: nearly four dozen firms

SEC, multiple years

The Blaszczak and Marwood cases were not isolated incidents. The SEC investigated nearly four dozen hedge funds, asset managers, and other investment firms for trading on non-public CMS information about Medicare reimbursement rate changes. The investigation spanned multiple years and identified multiple sources of leaked information across different political intelligence intermediaries. Healthcare stocks, whose valuations are extraordinarily sensitive to CMS reimbursement decisions, were the primary vehicle for the trading. A single CMS rate decision can move a medical device or pharmaceutical stock by double digits. The potential profit from advance knowledge of even a handful of decisions annually is substantial enough to sustain a multi-million-dollar intelligence operation built around it.

The sectors where political intelligence has the most market value

Not all government decisions move stocks. The sectors below are the ones where policy decisions are both high-stakes and predictable enough in advance that prior knowledge generates tradeable alpha.

Healthcare and pharmaceuticals

CMS covers over $850 billion in healthcare annually. A single reimbursement rate decision can move a medical device stock ten to twenty percent. FDA approval timelines, drug pricing legislation, and Medicare coverage determinations are among the most traded-upon government decisions in the market. The CMS cases described above sit entirely within this category.

Defense and procurement

The Pentagon budget exceeds $850 billion. Major contract awards, weapons program funding decisions, and procurement timelines are among the most consequential government actions for the equity valuations of defense contractors. Advance knowledge of a contract award decision, or the direction of a budget authorization, is exactly the kind of information political intelligence networks are built to capture.

Financial regulation

Banking capital requirements, derivatives rules, stress test outcomes, and the direction of Federal Reserve regulatory guidance all move financial sector stocks. Senate Finance and House Financial Services are among the committees where the gap between public knowledge and committee-level knowledge is widest. The people who sit on those committees are also the ones who can legally hold the stocks most affected by their decisions.

Technology and antitrust

FTC investigation outcomes, AI regulatory timelines, broadband subsidy allocation, and platform regulation all move the largest-cap stocks in the market. As technology companies have become more dependent on government policy for their competitive positions, the value of advance intelligence on regulatory intent has increased proportionally.

The line between smart analysis and illegal insider trading

Most of what political intelligence firms do is legal. Experienced analysts who understand how Congress and federal agencies work can draw inferences from public signals that most investors miss. Reading a budget justification document carefully, tracking a committee chair's public statements, noting which senators are quietly dropping their names from co-sponsorship of a bill: all of this is legitimate analysis that anyone with expertise and attention could do.

The line gets crossed when the information is material, non-public, and derived from someone with a duty of confidentiality. A congressional staffer who shares the outcome of a markup vote before the session happens has shared non-public information they were not authorized to share. A CMS analyst who tells a consulting firm the likely direction of a reimbursement decision before it is announced has done the same. The political intelligence firm that collects that information and sells it to a hedge fund that trades on it has participated in what the SEC considers a misappropriation of confidential government information.

The practical challenge is that the two things can look identical from outside. A skilled political intelligence analyst reaching the right conclusion through legitimate synthesis of public signals, and one who received a tip from a committee staffer, produce the same research note. The difference is in the source, which is invisible. This is why enforcement in this area is so rare: you need direct evidence of the communication, not just evidence that the trade was well-timed.

The structural gaps in the STOCK Act compound this problem. Even when insider trading on congressional information is suspected, the evidentiary bar for prosecution is high, the penalties are minimal, and the cases that do result in charges, like the Blaszczak case, typically require wiretaps, emails, or a cooperating witness. Without that level of evidence, the industry operates in a gray zone that is difficult to distinguish from very good research.

Why the industry persists and what that means for ordinary investors

Political intelligence persists for the same reason most information asymmetries persist: the people who benefit from it have more incentive to maintain it than the people harmed by it have power to change it. Hedge funds with access to political intelligence networks generate measurably better returns on government-sensitive holdings. The fees they pay are trivial compared to the trading advantage they receive. The firms selling the intelligence have no obligation to disclose what they do. And the congressional staff who are the ultimate source of the information flow face no individual penalty unless the SEC can prove, with direct evidence, that they knowingly shared material non-public information.

Academic research has found that hedge funds with political intelligence connections outperform non-connected funds by 63 to 86 basis points per month on politically sensitive positions. Annualized, that is roughly 7.5 to 10 percent of additional return attributable specifically to information advantage. On a billion-dollar fund, that is tens of millions of dollars per year. The intelligence industry did not grow to its current size by accident.

For ordinary investors, the practical implication is that some portion of the market's price discovery around government-sensitive events is happening through private information channels that are invisible in the public record. When a healthcare stock starts moving before a CMS announcement, some fraction of that move may reflect information that no amount of public analysis would have produced. The committee-level information advantages that lawmakers hold directly are one layer of this problem. The industry that has grown up to systematically harvest and resell that information is another, larger, and less visible one.

This is why the curation layer matters. What congressional disclosures show is the surface of the information picture: who traded what, in which direction, and approximately when. What they do not show is the broader context of what that member knew, who they were talking to, and what was on the legislative calendar at the time of the trade. That context, assembled from public sources and examined carefully, is as close as any public tool can get to the signal that political intelligence firms are extracting from their private networks.

Frequently asked questions

The legitimate version is legal. Analyzing publicly available government information, tracking regulatory calendars, forecasting policy outcomes based on expertise, and synthesizing public signals into investment research all fall within lawful activity. What is illegal, under the STOCK Act and SEC insider trading rules, is collecting and trading on material, non-public information from government officials who have a duty to keep it confidential. The challenge is that the two activities can look identical from the outside, and proving which occurred requires direct evidence of the communication that provided the non-public information.

Expert networks (firms like GLG, Guidepoint, and AlphaSense) connect investors with industry practitioners and former officials for due diligence calls. Political intelligence is a subset of this broader category, focused specifically on current government information rather than industry expertise. The distinction matters legally: a former CMS official discussing general reimbursement trends from public knowledge is operating an expert network call. A current CMS official sharing a pending rate decision before it is announced is supplying insider information, regardless of whether a firm is in the middle of the arrangement.

A disclosure requirement passed the Senate in 2012 with bipartisan support, 60 to 39. It was stripped in the House before the STOCK Act came to a final vote. Grassley introduced a standalone Political Intelligence Transparency Act in 2016. It did not move. The financial services industry's opposition to transparency requirements is well-funded and organized. There is also a definitional challenge: drawing a clear line between political intelligence and ordinary policy research is genuinely difficult, and any legislation broad enough to capture the industry could also sweep in journalists, academics, and think tanks. The combination of industry opposition and drafting complexity has been enough to block reform for over a decade.

Not fully. The private information networks at the heart of the political intelligence industry are, by design, inaccessible to the public. What individual investors can do is pay attention to the signals that are in the public record: who in Congress is trading, what they sit on, what was on the legislative calendar, and whether the timing of a trade aligns with the kind of committee knowledge that creates an edge. That is incomplete compared to what a hedge fund with a political intelligence retainer has access to, but it is the best available public signal. Congressional disclosures, cross-referenced against committee assignments and the legislative calendar, are the public version of what political intelligence firms sell at a premium.

The public version of political intelligence.

Kapitol.ai reviews every congressional trade against committee assignments, legislative timing, and context that raw disclosures don't contain. What reaches the feed is the signal, not the noise.